Schäfer-Korting M, Korting H C, Rittler W, Obermüller W
Fachbereich Pharmazie der Freien Universität Berlin, Germany.
Infection. 1995 Sep-Oct;23(5):292-7. doi: 10.1007/BF01716289.
Historically it has been assumed that the pharmacological effect is related to the free drug concentration. In exposing Candida albicans to itraconazole and ketoconazole serum concentration-time profiles, however, antifungal activity was not diminished despite intense albumin binding. The relevance of serum protein binding was further investigated, by in vitro susceptibility testing of C. albicans (40 clinical isolates) and Trichophyton rubrum (ten strains) against antifungal agents using microdilution tests allowing the determination of IC30- and MIC-values. The range of serum protein binding ranges from 11% with fluconazole to > 99% with itraconazole and terbinafine. The ratios of IC30- and MIC-values with and without serum protein (albumin, alpha- and gamma-globulin, human plasma) were related to the loss of susceptibility expected according to the free-drug hypothesis. A difference in the albumin effect with the test strains was not observed. With most antifungals including terbinafine, the activity declined as expected. IC30- and MIC-ratios for miconazole were 7 and 13 (observed) vs. 12-20 (expected), for fluconazole 1.5 and 3.5 vs. 1.1, for amphotericin B 10 vs. 11-20, for griseofulvin 3.6 vs. 4, and for terbinafine 61 vs. 100. Itraconazole activity, however, was not diminished by albumin (expected ratio 286), and ketoconazole effects decreased less than expected (ratio 5-15, expected about 100). alpha-globulin, but not gamma-globulin induced a major loss in anti-Candida activity of itraconazole and ketoconazole, which is paralleled by a decline in ketoconazole (but not itraconazole) activity due to plasma. With the other antifungals (except for ciclopiroxolamine) IC30-values for C. albicans increased, too. Due to the complete inhibition of T. rubrum growth by gamma-globulin, this species proved unsuitable for studying the gamma-globulin effects. The present study demonstrates that the effects of intense protein binding on drug activity are only partly predictable from binding studies in vitro.
从历史上看,人们一直认为药理作用与游离药物浓度有关。然而,在将白色念珠菌暴露于伊曲康唑和酮康唑的血清浓度-时间曲线时,尽管存在强烈的白蛋白结合,但抗真菌活性并未降低。通过使用微量稀释试验对白色念珠菌(40株临床分离株)和红色毛癣菌(10株菌株)进行体外药敏试验,进一步研究了血清蛋白结合的相关性,该试验可测定IC30值和MIC值。血清蛋白结合率的范围从氟康唑的11%到伊曲康唑和特比萘芬的>99%。根据游离药物假说,有血清蛋白(白蛋白、α和γ球蛋白、人血浆)和无血清蛋白时的IC30值和MIC值之比与预期的敏感性丧失有关。未观察到试验菌株在白蛋白作用上的差异。对于包括特比萘芬在内的大多数抗真菌药物,活性如预期的那样下降。咪康唑的IC30值和MIC值之比分别为7和13(观察值),而预期值为12 - 20;氟康唑分别为1.5和3.5,预期值为1.1;两性霉素B分别为10,预期值为11 - 20;灰黄霉素分别为3.6,预期值为4;特比萘芬分别为61,预期值为100。然而,伊曲康唑的活性并未因白蛋白而降低(预期比值为286),酮康唑的作用下降幅度小于预期(比值为5 - 15,预期约为100)。α球蛋白而非γ球蛋白导致伊曲康唑和酮康唑的抗念珠菌活性大幅丧失,同时血浆导致酮康唑(而非伊曲康唑)活性下降。对于其他抗真菌药物(除环吡酮胺外),白色念珠菌的IC30值也增加了。由于γ球蛋白完全抑制了红色毛癣菌的生长,该菌种被证明不适合用于研究γ球蛋白的作用。本研究表明,体外结合研究只能部分预测强烈的蛋白结合对药物活性的影响。